nodes	percent_of_prediction	percent_of_DWPC	metapath
Udenafil—PDE5A—clitoris—polycystic ovary syndrome	0.631	0.769	CbGeAlD
Udenafil—CYP3A4—urine—polycystic ovary syndrome	0.0371	0.0452	CbGeAlD
Udenafil—PDE5A—cGMP effects—PDE3B—polycystic ovary syndrome	0.0326	0.194	CbGpPWpGaD
Udenafil—PDE5A—Nitric oxide stimulates guanylate cyclase—PDE3B—polycystic ovary syndrome	0.0259	0.154	CbGpPWpGaD
Udenafil—PDE5A—adipose tissue—polycystic ovary syndrome	0.0254	0.0309	CbGeAlD
Udenafil—PDE5A—adrenal gland—polycystic ovary syndrome	0.0227	0.0277	CbGeAlD
Udenafil—PDE5A—female gonad—polycystic ovary syndrome	0.0212	0.0258	CbGeAlD
Udenafil—PDE5A—vagina—polycystic ovary syndrome	0.0211	0.0257	CbGeAlD
Udenafil—PDE5A—endocrine gland—polycystic ovary syndrome	0.0197	0.024	CbGeAlD
Udenafil—Sildenafil—CYP1A1—polycystic ovary syndrome	0.0108	1	CrCbGaD
Udenafil—CYP3A5—adipose tissue—polycystic ovary syndrome	0.0105	0.0128	CbGeAlD
Udenafil—PDE5A—Platelet homeostasis—PDE3B—polycystic ovary syndrome	0.0101	0.0599	CbGpPWpGaD
Udenafil—CYP3A5—female gonad—polycystic ovary syndrome	0.00881	0.0107	CbGeAlD
Udenafil—CYP3A5—vagina—polycystic ovary syndrome	0.00876	0.0107	CbGeAlD
Udenafil—CYP3A5—endocrine gland—polycystic ovary syndrome	0.00819	0.00999	CbGeAlD
Udenafil—CYP3A4—Benzo(a)pyrene metabolism—AKR1C2—polycystic ovary syndrome	0.00719	0.0427	CbGpPWpGaD
Udenafil—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00615	0.00749	CbGeAlD
Udenafil—PDE5A—Platelet homeostasis—GNAS—polycystic ovary syndrome	0.00406	0.0241	CbGpPWpGaD
Udenafil—CYP3A5—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.00402	0.0239	CbGpPWpGaD
Udenafil—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—polycystic ovary syndrome	0.004	0.0237	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—GP1BB—polycystic ovary syndrome	0.00337	0.02	CbGpPWpGaD
Udenafil—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—polycystic ovary syndrome	0.00308	0.0183	CbGpPWpGaD
Udenafil—CYP3A5—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.00287	0.017	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—PDE3B—polycystic ovary syndrome	0.00226	0.0134	CbGpPWpGaD
Udenafil—CYP3A4—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.00221	0.0131	CbGpPWpGaD
Udenafil—CYP3A5—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.0022	0.013	CbGpPWpGaD
Udenafil—CYP3A5—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00211	0.0125	CbGpPWpGaD
Udenafil—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—polycystic ovary syndrome	0.00202	0.012	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—RACGAP1—polycystic ovary syndrome	0.00194	0.0115	CbGpPWpGaD
Udenafil—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—polycystic ovary syndrome	0.00193	0.0115	CbGpPWpGaD
Udenafil—CYP3A4—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.00187	0.0111	CbGpPWpGaD
Udenafil—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.00154	0.00912	CbGpPWpGaD
Udenafil—CYP3A5—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.00152	0.009	CbGpPWpGaD
Udenafil—CYP3A5—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.00144	0.00855	CbGpPWpGaD
Udenafil—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.00143	0.00848	CbGpPWpGaD
Udenafil—CYP3A5—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.00141	0.00837	CbGpPWpGaD
Udenafil—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.00133	0.00792	CbGpPWpGaD
Udenafil—CYP3A5—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00125	0.0074	CbGpPWpGaD
Udenafil—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.00122	0.00724	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—PLAT—polycystic ovary syndrome	0.00118	0.00703	CbGpPWpGaD
Udenafil—CYP3A5—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00116	0.00688	CbGpPWpGaD
Udenafil—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00113	0.00671	CbGpPWpGaD
Udenafil—CYP3A5—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00112	0.00662	CbGpPWpGaD
Udenafil—CYP3A4—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.00111	0.00659	CbGpPWpGaD
Udenafil—CYP3A4—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.00102	0.00606	CbGpPWpGaD
Udenafil—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000982	0.00583	CbGpPWpGaD
Udenafil—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.000943	0.0056	CbGpPWpGaD
Udenafil—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000917	0.00544	CbGpPWpGaD
Udenafil—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000912	0.00541	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—GNAS—polycystic ovary syndrome	0.000909	0.00539	CbGpPWpGaD
Udenafil—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.0009	0.00534	CbGpPWpGaD
Udenafil—CYP3A5—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000801	0.00475	CbGpPWpGaD
Udenafil—CYP3A5—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000747	0.00444	CbGpPWpGaD
Udenafil—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000739	0.00439	CbGpPWpGaD
Udenafil—CYP3A5—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000737	0.00437	CbGpPWpGaD
Udenafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000715	0.00424	CbGpPWpGaD
Udenafil—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000705	0.00419	CbGpPWpGaD
Udenafil—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.00068	0.00403	CbGpPWpGaD
Udenafil—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000669	0.00397	CbGpPWpGaD
Udenafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000664	0.00394	CbGpPWpGaD
Udenafil—CYP3A5—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000662	0.00393	CbGpPWpGaD
Udenafil—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000656	0.00389	CbGpPWpGaD
Udenafil—CYP3A5—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000653	0.00388	CbGpPWpGaD
Udenafil—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.00065	0.00386	CbGpPWpGaD
Udenafil—CYP3A5—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000617	0.00366	CbGpPWpGaD
Udenafil—CYP3A5—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000615	0.00365	CbGpPWpGaD
Udenafil—CYP3A5—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000607	0.0036	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—IGF1—polycystic ovary syndrome	0.000588	0.00349	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—AKT2—polycystic ovary syndrome	0.000588	0.00349	CbGpPWpGaD
Udenafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000579	0.00344	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—SERPINE1—polycystic ovary syndrome	0.000559	0.00332	CbGpPWpGaD
Udenafil—CYP3A5—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000551	0.00327	CbGpPWpGaD
Udenafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000539	0.0032	CbGpPWpGaD
Udenafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000526	0.00312	CbGpPWpGaD
Udenafil—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000524	0.00311	CbGpPWpGaD
Udenafil—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000519	0.00308	CbGpPWpGaD
Udenafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000505	0.003	CbGpPWpGaD
Udenafil—CYP3A5—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000487	0.00289	CbGpPWpGaD
Udenafil—CYP3A5—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.00048	0.00285	CbGpPWpGaD
Udenafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000426	0.00253	CbGpPWpGaD
Udenafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000424	0.00252	CbGpPWpGaD
Udenafil—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000418	0.00248	CbGpPWpGaD
Udenafil—CYP3A5—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000393	0.00233	CbGpPWpGaD
Udenafil—CYP3A5—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000387	0.0023	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—VEGFA—polycystic ovary syndrome	0.000384	0.00228	CbGpPWpGaD
Udenafil—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000372	0.00221	CbGpPWpGaD
Udenafil—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000347	0.00206	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—NMNAT3—polycystic ovary syndrome	0.000345	0.00205	CbGpPWpGaD
Udenafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000344	0.00204	CbGpPWpGaD
Udenafil—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000343	0.00203	CbGpPWpGaD
Udenafil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000316	0.00188	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—LPCAT2—polycystic ovary syndrome	0.000316	0.00187	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—SUOX—polycystic ovary syndrome	0.000316	0.00187	CbGpPWpGaD
Udenafil—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000308	0.00183	CbGpPWpGaD
Udenafil—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000304	0.0018	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—ISYNA1—polycystic ovary syndrome	0.000294	0.00174	CbGpPWpGaD
Udenafil—CYP3A5—Biological oxidations—POMC—polycystic ovary syndrome	0.000293	0.00174	CbGpPWpGaD
Udenafil—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000287	0.0017	CbGpPWpGaD
Udenafil—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000286	0.0017	CbGpPWpGaD
Udenafil—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000282	0.00167	CbGpPWpGaD
Udenafil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000256	0.00152	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—AKR1C2—polycystic ovary syndrome	0.00025	0.00148	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—TEAD2—polycystic ovary syndrome	0.00025	0.00148	CbGpPWpGaD
Udenafil—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000226	0.00134	CbGpPWpGaD
Udenafil—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000223	0.00133	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—PNPLA2—polycystic ovary syndrome	0.000209	0.00124	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—SRD5A1—polycystic ovary syndrome	0.000198	0.00118	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—STAR—polycystic ovary syndrome	0.000189	0.00112	CbGpPWpGaD
Udenafil—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000183	0.00108	CbGpPWpGaD
Udenafil—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.00018	0.00107	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—HMMR—polycystic ovary syndrome	0.000169	0.001	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—HSD3B1—polycystic ovary syndrome	0.000161	0.000955	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000161	0.000953	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000147	0.000872	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000147	0.000872	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—LHB—polycystic ovary syndrome	0.000147	0.000871	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	0.000143	0.000851	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	0.000139	0.000824	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000137	0.00081	CbGpPWpGaD
Udenafil—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000136	0.000808	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	0.000128	0.000759	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	0.000124	0.000735	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	0.000119	0.000708	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000116	0.000689	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000116	0.000689	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	0.000115	0.00068	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	0.000113	0.000672	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	0.000107	0.000635	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	0.000105	0.000625	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	9.73e-05	0.000577	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	9.22e-05	0.000547	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—TH—polycystic ovary syndrome	9.11e-05	0.000541	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	8.86e-05	0.000526	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	8.8e-05	0.000522	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	8.33e-05	0.000494	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	7.84e-05	0.000465	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	7.48e-05	0.000444	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	7.43e-05	0.000441	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	7.08e-05	0.00042	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	6.82e-05	0.000405	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	6.71e-05	0.000398	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	6.67e-05	0.000396	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	6.46e-05	0.000383	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	6.26e-05	0.000371	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	5.94e-05	0.000353	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	5.75e-05	0.000342	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	5.55e-05	0.000329	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	5.33e-05	0.000316	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	5.26e-05	0.000312	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	5.08e-05	0.000301	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	5.01e-05	0.000297	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—INS—polycystic ovary syndrome	4.98e-05	0.000295	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	4.97e-05	0.000295	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	4.89e-05	0.00029	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—TH—polycystic ovary syndrome	4.23e-05	0.000251	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	4.12e-05	0.000244	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	3.87e-05	0.00023	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	3.46e-05	0.000205	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.29e-05	0.000195	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	3.12e-05	0.000185	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	2.91e-05	0.000173	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.36e-05	0.00014	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.33e-05	0.000138	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.31e-05	0.000137	CbGpPWpGaD
